METHOD AND SYSTEM FOR MANAGING LIFESTYLE AND HEALTH INTERVENTIONS
Provided herein are methods and systems for managing lifestyle and health interventions. The methods and systems described herein can improve health outcomes for a variety of lifestyle intervention regimens. Described herein are methods and systems for providing an interface for a human subject, collecting subject-specific data entered by the human subject, and comparing the subject-specific data to a database of entry activity by prior subjects. The methods and systems can further provide the subject with milestone achievement input derived from the entry activity of the subject that predicts the likelihood of success in achieving a desired outcome. The methods and systems described herein can be used for addressing a variety of lifestyle-related health conditions including without limitation body weight and cardiometabolic disorders such as type-II diabetes.
1 . A method for improving a lifestyle-related health condition of a subject, said method comprising:
a. providing to said subject a digital interface for:
i. receiving a lifestyle intervention regimen to achieve a lifestyle-related health condition milestone;
ii. entering subject-specific data for one or more validated compliance parameters associated with said lifestyle-related health condition milestone; and
iii. optionally collecting body metric measurements; and
b. receiving from said subject and via the digital interface, said subject-specific data for one or more validated compliance parameters associated with said lifestyle-related health condition milestone;
c. comparing entry activity comprised of a rate and/or number of said subject-specific data received from said subject via the digital interface with a database of entry activity by prior subjects; and
d. providing said subject with milestone achievement input, wherein said milestone achievement input is derived, at least in part, from the entry activity comprised of the rate and/or number of subject-specific data received from said subject via said digital interface, and predicts the subject's likelihood of success in achieving the lifestyle-related health condition milestone at a future date.
2 . A method for treating a subject having or at risk of having a cardiometabolic disorder, said method comprising:
a. providing to said subject a digital interface for:
i. receiving a lifestyle intervention regimen to achieve a therapeutic milestone for said cardiometabolic disorder;
ii. entering subject-specific data for one or more validated compliance parameters associated with said therapeutic milestone for said cardiometabolic disorder; and
iii. optionally collecting body metric measurements; and
b. receiving from said subject and via the digital interface, said subject-specific data for one or more validated compliance parameters associated with said therapeutic milestone;
c. comparing entry activity comprised of a rate or number of said subject-specific data received from said subject via the digital interface with a database of entry activity by prior subjects; and
d. providing said subject with milestone achievement input, wherein said milestone achievement input is derived, at least in part, from the entry activity comprised of the rate and/or number of subject-specific data received from said subject via said digital interface, and predicts the subject's likelihood of success in achieving the therapeutic milestone for said cardiometabolic disorder at a future date.
3 . The method according to claim 1 or 2 , wherein said lifestyle intervention regimen is selected from the group consisting of a dietary regimen and an activity regimen.
4 . The method according to claim 3 , wherein said lifestyle intervention regimen comprises a dietary regimen, and said dietary regimen comprises a plant based diet.
5 . The method of claim 4 , wherein said dietary regimen further comprises vegetables, fruit, legumes, nuts and seeds, and whole grains.
6 . The method according to claim 4 , wherein said plant-based diet comprises recipes, ingredients and local ingredient acquisition locations.
7 . The method according to claim 3 , wherein said validated compliance parameters comprise compliance parameters selected from the group consisting of:
a. generate meal plan;
b. follow meal plan;
c. procure ingredients from a shopping list;
d. engage with digital interface;
e. log daily targets
f. log hydration; and
g. communicate with coach.
8 . The method according to claim 7 , wherein said validated compliance parameters comprise at least 2, 3, 4, 5, or 6 of the compliance parameters selected from the group consisting of:
a. generate meal plan;
b. follow meal plan;
c. procure ingredients from a shopping list;
d. engage with digital interface;
e. log daily targets
f. log hydration; and
g. communicate with coach.
9 . The method according to claim 1 or 2 , wherein said lifestyle intervention comprises the activity regimen, and said daily activity regimen comprises a type, intensity and frequency of exercise, a daily caloric burn target, or a combination thereof.
10 . The method according to claim 9 , wherein said lifestyle intervention further comprises the dietary regimen.
11 . The method according to claim 1 or 2 , wherein said method comprises collecting body weight metric measurements of said subject via the digital interface and said milestone achievement input is further derived from the body metric measurements of said subject collected via the digital interface.
12 . The method according to claim 1 or 2 , wherein said lifestyle-related health condition milestone or therapeutic milestone for said cardiometabolic disorder comprises weight loss.
13 . The method according to claim 2 , wherein said cardiometabolic disorder is diabetes, and said therapeutic milestone comprises maintenance of HbA1c, fasting glucose, fasting insulin, alanine transaminase, and/or fasting lipids at a level indicative of therapeutic benefit for a subject having or at risk of having type-II diabetes.
14 . The method according to claim 13 , wherein the method comprises achieving said therapeutic milestone without pharmaceutical intervention, or with a reduced dosing of one or more pharmaceutical interventions.
15 . (canceled)
16 . The method according to claim 2 , wherein said cardiometabolic disorder is heart disease, and said therapeutic milestone is selected from the group consisting of:
a. weight loss;
b. improved lipid profile;
c. lower blood pressure; and
d. lower resting pulse rate.
17 . The method according to claim 16 , wherein the method comprises achieving said therapeutic milestone without pharmaceutical intervention, or with a reduced dosing of one or more pharmaceutical interventions.
18 . The method according to claim 17 , wherein said pharmaceutical intervention(s) comprise one or more interventions selected from the group consisting of: a beta-blocking agent, an alpha-blocking agent, an angiotensin-converting enzyme inhibitor, a statin, a diuretic, and a calcium channel blocker.
19 . The method according to claim 2 , wherein said cardiometabolic disorder is hypertension and said therapeutic milestone comprises maintenance of a diastolic and/or systolic blood pressure at a level indicative of therapeutic benefit for a subject having or at risk of having hypertension.
20 . The method according to claim 19 , wherein the method comprises achieving said therapeutic milestone without pharmaceutical intervention, or with a reduced dosing of one or more pharmaceutical interventions.
21 . The method according to claim 20 , wherein said pharmaceutical intervention(s) comprise one or more interventions selected from the group consisting of: a beta-blocking agent, an alpha-blocking agent, an angiotensin-converting enzyme inhibitor, an angiotensin II receptor blocker, a calcium channel blocker, a diuretic, and a renin inhibitor.
22 . The method according to claim 2 , wherein said cardiometabolic disorder is hyperlipidemia and said therapeutic milestone is improved lipid profile.
23 . The method according to claim 22 , wherein the method comprises achieving said therapeutic milestone without pharmaceutical intervention, or with a reduced dosing of one or more pharmaceutical interventions.
24 . (canceled)
25 . The method according to claim 2 , wherein said cardiometabolic disorder is coronary artery disease and said therapeutic milestone is selected from the group consisting of:
a. weight loss;
b. improved lipid profile;
c. lower blood pressure;
d. increased stamina;
e. reduced angina;
f. reduced fluid retention;
g. increased coronary arterial blood flow; and
h. reduced arterial plaque.
26 . The method according claim 25 , wherein the method comprises achieving said therapeutic milestone without pharmaceutical intervention, or with a reduced dosing of one or more pharmaceutical interventions.
27 . The method according to claim 26 , wherein said pharmaceutical intervention(s) comprise one or more interventions selected from the group consisting of:
a. a cholesterol-modifying medication selected from the group consisting of a statin, exetimibe, and PCSK9 inhibitors;
b. an anti-coagulant, preferably selected from the group consisting of an anti-platelet agent (e.g. aspirin or Plavix), warfarin, low-molecular weight heparin, a direct thrombin inhibitor, and a factor Xa inhibitor;
c. a beta-blocking agent,
d. a vasodilator;
e. a diuretic; and
f. an angiotensin-converting enzyme inhibitor and an angiotensin II receptor blocking agent.
28 . The method according to any claim 1 or 2 , wherein said milestone achievement input is provided by a reference physician.
29 . The method according to claim 1 or 2 , further comprising: step e) initiating direct personal feedback to said subject or increasing the level of direct personal feedback provided to said subject when said subject is predicted to be likely to miss their milestone.
30 . The method according to claim 1 or 2 , wherein said providing to said subject the digital interface comprises transmitting the digital interface from a digital interface server to a user local display.
31 . The method of claim 30 , wherein said user local display is a component of a user local device, wherein said user local device comprises the user-local display, a user local processor, and a user local datalink.
32 . The method according to claim 31 , wherein said receiving from said subject said subject-specific data comprises receiving one or more transmissions comprising said subject-specific data:
a. from said user local datalink; and
b. to a comparison engine.
33 . The method according to claim 1 or 2 , wherein said providing said subject with milestone achievement input comprises transmitting computer readable instructions to said user-local device through said user-local datalink, wherein said computer readable instructions are configured to display a message comprising said input on said user-local display.
34 . The method according to claim 33 , wherein said message comprises a pre-configured communication indicating likelihood of success.
35 . The method of claim 34 , wherein said message further comprises a pre-configured communication indicating an additional lifestyle intervention for increasing likelihood of success.
36 . The method of claim 35 , wherein said communication indicating an additional lifestyle intervention for increasing likelihood of success is a message indicating an amount of increase in one or more validated compliance parameters to achieve a predicted likelihood of success.
37 . The method of claim 35 , wherein said communication indicating an additional lifestyle intervention for increasing likelihood of success comprises an invitation to one-on-one or small-group coaching with a nurse practitioner, clinician, chef-educator, behavioral psychologist, or a combination thereof.
38 . The method according to claim 33 , wherein said message comprises a pre-configured communication requesting entry of subject-specific data via the digital interface.
39 . The method according to claim 33 , wherein said message comprises an interface with an automated chat module.
40 . A system for performing a method according to claim 1 or 2 .
41 . A computer readable medium for performing a method according to claim 1 or 2 .